Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic
Valeria Visconte1, Ali Tabarroki, Christopher J Gerace
1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA.
Leukemia & Lymphoma
|October 21, 2014
Abstract
No abstract available in PubMed .


